B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 59 CAD 4.8%
Market Cap: 263.4m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
EPS (Diluted) Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
EPS (Diluted)
-CA$1
CAGR 3-Years
-73%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
EPS (Diluted)
$0
CAGR 3-Years
42%
CAGR 5-Years
8%
CAGR 10-Years
8%
Repare Therapeutics Inc
NASDAQ:RPTX
EPS (Diluted)
-$2
CAGR 3-Years
-15%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
EPS (Diluted)
$0
CAGR 3-Years
49%
CAGR 5-Years
25%
CAGR 10-Years
10%
Covalon Technologies Ltd
XTSX:COV
EPS (Diluted)
CA$0
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
EPS (Diluted)
CA$0
CAGR 3-Years
-31%
CAGR 5-Years
-55%
CAGR 10-Years
-3%

See Also

What is Bright Minds Biosciences Inc's EPS (Diluted)?
EPS (Diluted)
-2 CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's EPS (Diluted) amounts to -2 CAD.

What is Bright Minds Biosciences Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-73%

Over the last year, the EPS (Diluted) growth was 67%. The average annual EPS (Diluted) growth rates for Bright Minds Biosciences Inc have been -73% over the past three years .

Back to Top